These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 34175541
41. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents. Stefański T, Mikstacka R, Kurczab R, Dutkiewicz Z, Kucińska M, Murias M, Zielińska-Przyjemska M, Cichocki M, Teubert A, Kaczmarek M, Hogendorf A, Sobiak S. Eur J Med Chem; 2018 Jan 20; 144():797-816. PubMed ID: 29291446 [Abstract] [Full Text] [Related]
42. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Wang G, Li C, He L, Lei K, Wang F, Pu Y, Yang Z, Cao D, Ma L, Chen J, Sang Y, Liang X, Xiang M, Peng A, Wei Y, Chen L. Bioorg Med Chem; 2014 Apr 01; 22(7):2060-79. PubMed ID: 24629450 [Abstract] [Full Text] [Related]
43. Discovery of novel indole-1,2,4-triazole derivatives as tubulin polymerization inhibitors. Wu MK, Man RJ, Liao YJ, Zhu HL, Zhou ZG. Drug Dev Res; 2021 Nov 01; 82(7):1008-1020. PubMed ID: 33675542 [Abstract] [Full Text] [Related]
44. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity. Naaz F, Preeti Pallavi MC, Shafi S, Mulakayala N, Shahar Yar M, Sampath Kumar HM. Bioorg Chem; 2018 Dec 01; 81():1-20. PubMed ID: 30081353 [Abstract] [Full Text] [Related]
45. Identification of new 3-phenyl-1H-indole-2-carbohydrazide derivatives and their structure-activity relationships as potent tubulin inhibitors and anticancer agents: A combined in silico, in vitro and synthetic study. Saruengkhanphasit R, Butkinaree C, Ornnork N, Lirdprapamongkol K, Niwetmarin W, Svasti J, Ruchirawat S, Eurtivong C. Bioorg Chem; 2021 May 01; 110():104795. PubMed ID: 33730670 [Abstract] [Full Text] [Related]
46. Design and Antiproliferative Evaluation of Novel Sulfanilamide Derivatives as Potential Tubulin Polymerization Inhibitors. Fu DJ, Liu JF, Zhao RH, Li JH, Zhang SY, Zhang YB. Molecules; 2017 Sep 05; 22(9):. PubMed ID: 28872607 [Abstract] [Full Text] [Related]
47. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R, Kimatrai Salvador M, Schiaffino Ortega S, Baraldi PG, Oliva P, Baraldi S, Lopez-Cara LC, Brancale A, Ferla S, Hamel E, Balzarini J, Liekens S, Mattiuzzo E, Basso G, Viola G. Eur J Med Chem; 2018 Jan 01; 143():683-698. PubMed ID: 29220790 [Abstract] [Full Text] [Related]
48. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors. Xu S, An B, Li Y, Luo X, Li X, Jia X. Bioorg Med Chem Lett; 2018 Jun 01; 28(10):1769-1775. PubMed ID: 29673981 [Abstract] [Full Text] [Related]
49. Synthesis, biological evaluation and molecular docking of benzimidazole grafted benzsulfamide-containing pyrazole ring derivatives as novel tubulin polymerization inhibitors. Wang YT, Shi TQ, Zhu HL, Liu CH. Bioorg Med Chem; 2019 Feb 01; 27(3):502-515. PubMed ID: 30606674 [Abstract] [Full Text] [Related]
50. Synthesis and biological evaluation of (1-aryl-1H-pyrazol-4-yl) (3,4,5-trimethoxyphenyl)methanone derivatives as tubulin inhibitors. Zhai M, Wang L, Liu S, Wang L, Yan P, Wang J, Zhang J, Guo H, Guan Q, Bao K, Wu Y, Zhang W. Eur J Med Chem; 2018 Aug 05; 156():137-147. PubMed ID: 30006160 [Abstract] [Full Text] [Related]
51. Design, synthesis and biological evaluation of benz-fused five-membered heterocyclic compounds as tubulin polymerization inhibitors with anticancer activities. Komuraiah B, Ren Y, Xue M, Cheng B, Liu J, Liu Y, Chen J. Chem Biol Drug Des; 2021 May 05; 97(5):1109-1116. PubMed ID: 33638903 [Abstract] [Full Text] [Related]
52. Synthesis and biological evaluation of 1-(benzofuran-3-yl)-4-(3,4,5-trimethoxyphenyl)-1H-1,2,3-triazole derivatives as tubulin polymerization inhibitors. Qi ZY, Hao SY, Tian HZ, Bian HL, Hui L, Chen SW. Bioorg Chem; 2020 Jan 05; 94():103392. PubMed ID: 31669093 [Abstract] [Full Text] [Related]
53. Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines. Huo XS, Jian XE, Ou-Yang J, Chen L, Yang F, Lv DX, You WW, Rao JJ, Zhao PL. Eur J Med Chem; 2021 Aug 05; 220():113449. PubMed ID: 33895499 [Abstract] [Full Text] [Related]
55. Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors. Wang G, Liu W, Gong Z, Huang Y, Li Y, Peng Z. Bioorg Chem; 2020 Jan 05; 95():103565. PubMed ID: 31927336 [Abstract] [Full Text] [Related]
56. Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors. Donthiboina K, Anchi P, Gurram S, Sai Mani G, Lakshmi Uppu J, Godugu C, Shankaraiah N, Kamal A. Bioorg Chem; 2020 Oct 05; 103():104191. PubMed ID: 32891862 [Abstract] [Full Text] [Related]
59. Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold. Xu Q, Sun M, Bai Z, Wang Y, Wu Y, Tian H, Zuo D, Guan Q, Bao K, Wu Y, Zhang W. Eur J Med Chem; 2017 Oct 20; 139():242-249. PubMed ID: 28802124 [Abstract] [Full Text] [Related]